Colorectal Cancer Coalition

• Statement on Erythropoietin Stimulating Agents (ESAs), 3/13/2008
• Comments Regarding Medicare Coverage for Virtual Colonoscopies, 6/18/2008
• Research, Condition, and Disease Categorization (RCDC) system, 7/9/2008
• C3 Comments on KRAS Testing to FDA ODAC Committee, 12/16/2008
• The Colon Cancer Screen for Life Act, updated 1/9/2009
• The Colorectal Cancer Prevention, Early Detection, and Treatment Act, updated 1/9/2009
• The National Cancer Fund Act, 1/9/2009
• Comments on the CMS National Coverage Decision not to Cover Screening CT Colonography, 3/9/2009
• 21st Century ALERT Act, 4/1/2009
• Comments to ARTD Panel Regarding Sedasys CAPS, 5/28/2009
• Comments to the FDA Transparency Task Force, 7/1/2009

Where We Stand on the Issues

C3 regularly develops policy documents, submits testimony and speaks out on issues impacting colorectal cancer patients. Browse through our published opinions by subject below, or in order of publication at right.

Affordable Screenings

• The Colon Cancer Screen for Life Act (to amend title XVIII of the Social Security Act to increase Medicare Part B), 1/9/2009
• The Colorectal Cancer Prevention, Early Detection and Treatment Act (to create a National Colorectal Cancer Screening Program), 1/9/2009

Cancer Research

• The National Cancer Fund Act (to expand federally funded cancer research and control programs), 1/9/2009
• Research, Condition, and Disease Categorization system (to provide better accuracy and transparency in cancer research funding), 7/9/2008
• 21st Century ALERT Act (letter to bill’s sponsors, Senators Ted Kennedy and Kay Bailey Hutchison), 4/1/2009

Computer-Assisted Personalized Sedation

• Statement to the Anesthesiology and Respiratory Therapy Devices Panel regarding the Sedasys® Computer-Assisted Personalized Sedation system, 5/28/2009

Drug Approval

• Comments to the FDA Transparency Task Force, 7/1/2009

Erythropoietin Stimulating Agents (ESAs)

• Statement to the Oncologic Drug Advisory Committee regarding safety concerns of Erythropoietin Stimulating Agents, 3/13/2008

Personalized Medicine

• Statement to the Oncologic Drug Advisory Committee regarding a label change for Erbitux (cetuximab) and Vectibix (panitumumab) in regards to KRAS status, 12/16/2008

Virtual Colonoscopy

• Comments regarding Medicare Coverage for virtual colonoscopies, 6/18/2008
• Comments regarding CMS decision to not cover virtual colonoscopies, 3/9/2009

Check back regularly for updated position papers.

Last Update: July 1, 2009